« PreviousNext »Journal of the American Academy of Dermatology
Volume 63, Issue 2 , Pages 252-258, August 2010
Volume 63, Issue 2 , Pages 252-258, August 2010
Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study
To access this article, please choose from the options below
Supported by GlaxoSmithKline.
Conflicts of interest: None declared.
PII: S0190-9622(09)01213-4
doi:10.1016/j.jaad.2009.09.018
© 2009 American Academy of Dermatology, Inc. Published by Elsevier Inc All rights reserved.
« PreviousNext »Journal of the American Academy of Dermatology
Volume 63, Issue 2 , Pages 252-258, August 2010
Volume 63, Issue 2 , Pages 252-258, August 2010
